Connect with us

Emerging Markets

Ilustrato Pictures International Inc (OTCMKTS: ILUS) Looking to Breakout as M&A Player Reports Record Revenues, Up Listing to National Exchange & Major League Acquistion

Published

on

ILUS International Inc (OTCMKTS: ILUS) is looking to breakout northbound after the Company announced it is acquiring a Company that did $100 million in revenues in 2021 and is on track to achieve over $200 million in 2022. The acquisition target is a large process equipment manufacturer, focused primarily on the Oil, Gas and Utility industries and which also manufactures firefighting equipment for special projects. The agreed acquisition, acquisition number 7 for the Company is headquartered in the Middle East where its manufacturing and assembly facilities extend to over 10 million square feet. Ilustrato is also nearing its first defense acquisition, which manufactures disruptive technology and vehicles for the defense sector. In addition to the completion of the Defense acquisition, ILUS is also acquiring an emergency response communications Company, a wildfire equipment Manufacturer and more as Ilustrato continues to add valuable assets to its Emergency Response Technologies portfolio.  

ILUS has been undergoing an audit by AJSH & Co LLP which is nearing completion and this will get the Company to fully reporting OTCQB, reviewing options for shareholders in preparation for planned up listing to a Major US Stock Exchange. ILUS is also in discussions with several investment banks to evaluate options and scenarios. ILUS was one of the biggest runners of 2021 skyrocketing from well under a penny to highs of $0.509 per share. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

ILUS International Inc (OTCMKTS: ILUS) is a Mergers and Acquisitions company focused on acquiring and developing public safety technology-based companies across the globe. Having already acquired 7 companies since January 2021, ILUS is in the process of agreeing and completing several new acquisitions for its Emergency Response Technologies subsidiary. 

ILUS reported Q1 2022 revenue of $3,013,522 representing a 482% increase over its revenue in Q1 2021. The company also reported a 73% increase in its balance sheet for the same period to $34,381,723, its highest reported balance sheet to date. With customer behavior varying between quarters due to seasonal and cyclical trends, the third and fourth quarters of each year are often the strongest for businesses in the manufacturing and distribution industries. ILUS is therefore optimistic about its Quarter-on-Quarter growth, which is most relevant when analyzing and improving the progress of each of its acquisitions. Additional highlights in the company’s Profit and Loss statement for the first quarter included a gross profit of $1,859,080, up more than $1.6 million on the same period in 2021, and an increased net profit of $636,636. With a strong balance sheet, consistently growing revenue, several larger agreed acquisitions to be added and solid investor backing, ILUS remains in an incredibly healthy position as the company rapidly closes in on its most significant milestones yet.  

Earlier this year ILUS formed a new Defense subsidiary and the Company is now nearing its first defense acquisition, which manufactures disruptive technology and vehicles for the defense sector. In addition to the completion of the agreed upon acquisition, ILUS is also acquiring an emergency response communications Company, a wildfire equipment Manufacturer and more as the Company continues to add valuable assets to its Emergency Response Technologies portfolio.  

https://twitter.com/stockplayer112/status/1529553461045608450

To Find out the inside Scoop on ILUS Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

ILUS

ILUS has been undergoing its audit by AJSH & Co LLP which is nearing completion and this will get them to fully reporting OTCQB, reviewing options for shareholders to lock up shares in a preference category, finalizing structure for the roll out of its European deals and restructuring its subsidiaries in preparation for planned participation on a major stock exchange. As the deal size and complexity of its acquisitions has grown significantly in preparation for the planned participation on a major stock exchange, ILUS is in discussions with reputable investment banks to evaluate several options and scenarios.  

ILUS made significant operational progress during the first quarter of 2022. In addition to its two completed and two agreed acquisitions, the company opened new offices in Dubai, UAE and Boca Raton, FL, USA. The ILUS global headquarters in Dubai have capacity for up to 80 team members whilst its US regional office in Boca Raton has capacity for up to 15. The company made several new hires during the first quarter, especially in its administrative and finance departments as it ramped up activity for its audit and a potential up listing.  

On May 25 ILUS announced it has agreed to the principal terms to acquire its first $100 million revenue company. The agreed acquisition delivered upwards of $100 million in 2021 revenue and is on track to achieve over $200 million in 2022. ILUS is pleased to announce that following months of discussions and due diligence, the terms have been agreed for the acquisition of a large process equipment manufacturer which is focused primarily on the Oil, Gas and Utility industries and which also manufactures firefighting equipment for special projects. The company is a leading provider of heavy engineering solutions and turnkey projects with an extensive list of global multinationals as customers. The agreed acquisition is headquartered in the Middle East where its manufacturing and assembly facilities extend to over 10 million square feet.  

Following completion of the first round of due diligence, the heads of terms for the acquisition and documentation have been agreed. The attorneys are satisfied and have begun work on the contracts whilst the second round of due diligence is already underway. ILUS and the agreed acquisition hope to complete the remaining due diligence and contractual process within approximately thirty days. ILUS will structure the agreed acquisition within its Emergency Response Technologies subsidiary, alongside a group of several strategically aligned manufacturing and technology companies. Emergency Response Technologies has simultaneously agreed the acquisition of a fully reporting Special Purpose Vehicle (SPV) and it is intended that the agreed acquisition will be reversed into this SPV. More detailed information on the structure of the deals will be announced closer to or at their completion. 

  For More on ILUS Subscribe Right Now!

Currently trading at a $122 million market valuation ILUS has half a million dollars in the treasury and $34 million in assets and $15 million in liabilities. ILUS Is on the move northbound since a brif dip below the $0.10 mark. The Company just announced it is acquiring a Company that did $100 million in revenues in 2021 and is on track to achieve over $200 million in 2022. Ilustrato is also nearing its first defense acquisition, which manufactures disruptive technology and vehicles for the defense sector. In addition to the completion of the Defense acquisition, ILUS is also acquiring an emergency response communications Company, and a wildfire equipment Manufacturer. ILUS is an attractive bet for investors at current levels, with 7 acquisitions already completed and many more on the way, record revenues and legions of new shareholders jumping on board, ILUS has a massive gap to fill back to $0.50 per share. Microcapdaily first reported on ILUS on August 15, 2021 when the stock was $0.06 on its way to $0.50 per share. We will be updating on ILUS when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with ILUS.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in ILUS either long or short and we have not been compensated for this article.

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

on

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

on

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.